Free Trial

American Century Companies Inc. Boosts Holdings in Siga Technologies Inc. $SIGA

Siga Technologies logo with Medical background

Key Points

  • American Century Companies Inc. increased its stake in Siga Technologies by 7.8%, acquiring a total of 1,370,660 shares worth approximately $7.5 million as of its latest SEC filing.
  • Other hedge funds, including Dimensional Fund Advisors and Northern Trust Corp, also boosted their positions in Siga Technologies, resulting in institutional investors now owning 55.40% of the company's stock.
  • Wall Street analysts upgraded Siga Technologies from a "hold" to a "strong-buy" rating, indicating positive growth expectations for the company.
  • Interested in Siga Technologies? Here are five stocks we like better.

American Century Companies Inc. increased its position in Siga Technologies Inc. (NASDAQ:SIGA - Free Report) by 7.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,370,660 shares of the company's stock after acquiring an additional 98,688 shares during the quarter. American Century Companies Inc. owned about 1.92% of Siga Technologies worth $7,511,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Harbor Capital Advisors Inc. boosted its position in shares of Siga Technologies by 31.8% in the first quarter. Harbor Capital Advisors Inc. now owns 222,012 shares of the company's stock valued at $1,217,000 after acquiring an additional 53,534 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Siga Technologies by 11.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,126,065 shares of the company's stock valued at $12,777,000 after acquiring an additional 217,926 shares during the period. Legal & General Group Plc boosted its position in shares of Siga Technologies by 12.6% in the fourth quarter. Legal & General Group Plc now owns 59,944 shares of the company's stock valued at $360,000 after acquiring an additional 6,704 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of Siga Technologies by 26.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 40,005 shares of the company's stock valued at $241,000 after acquiring an additional 8,290 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Siga Technologies by 28.1% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 134,382 shares of the company's stock valued at $808,000 after acquiring an additional 29,442 shares during the period. 55.40% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of Siga Technologies from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 9th.

Get Our Latest Analysis on SIGA

Siga Technologies Trading Up 2.9%

Shares of SIGA stock traded up $0.24 during trading hours on Tuesday, hitting $8.63. 819,633 shares of the company's stock were exchanged, compared to its average volume of 653,888. The company has a market capitalization of $617.99 million, a PE ratio of 7.64 and a beta of 0.95. Siga Technologies Inc. has a 12-month low of $4.95 and a 12-month high of $9.62. The business's 50 day simple moving average is $7.51 and its 200-day simple moving average is $6.44.

Siga Technologies (NASDAQ:SIGA - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.49 EPS for the quarter. The firm had revenue of $81.12 million for the quarter. Siga Technologies had a net margin of 45.73% and a return on equity of 40.52%. Equities analysts anticipate that Siga Technologies Inc. will post 1.04 EPS for the current year.

About Siga Technologies

(Free Report)

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Featured Stories

Institutional Ownership by Quarter for Siga Technologies (NASDAQ:SIGA)

Should You Invest $1,000 in Siga Technologies Right Now?

Before you consider Siga Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Siga Technologies wasn't on the list.

While Siga Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines